Tenders/HI-6 Dimethanesulfonate (DMS) and Atropine Sulfate Reconstitution Autoinjector Device (RAD) Feasibility Assessment

Open🇨🇦CanadaConsulting

HI-6 Dimethanesulfonate (DMS) and Atropine Sulfate Reconstitution Autoinjector Device (RAD) Feasibility Assessment

Department of National Defence (DND)

Published: Jun 2, 2026

Updated: Jun 3, 2026

Source: CanadaBuys - Government of Canada

About This Opportunity

This is a consulting contract in the architecture and engineering, health and medical services and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Canada, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before June 16, 2026.

Published through CanadaBuys - Government of Canada, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for consulting in the architecture and engineering sector. Consulting assignments are typically evaluated with a strong emphasis on the technical proposal, including the methodology and qualifications of key experts. Shortlisted firms may be invited to submit financial proposals in a second stage. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

The Department of National Defence (DND), specifically the Canadian Forces Health Services (CFHS), has a requirement for the services of a Contractor to test and evaluate the feasibility of manufacturing HI-6 DMS and atropine sulfate drug products in a reconstitution autoinjector device (RAD). The scope of this requirement is to conduct a feasibility assessment using an existing prototype of a RAD with the configuration of HI-6 DMS in the dry chamber (500 mg +/- 25%) and 1 mL atropine (2 mg/mL) in the liquid chamber. The work will involve the following: • Project Management. • Analytical Method Development. • Material Processing and Performance Assessments. • Mixing and Drug Delivery Model. • Sterilization Impact Assessment.. UNSPSC: *Feasibility studies or screening of project ideas (*80101601). Method: Advance contract award notice. Selection: Not applicable. Trade Agreements: *Please refer to Tender Description or Tender Documents

Data provenance

This notice is sourced from CanadaBuys - Government of Canada and was originally published on June 2, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Department of National Defence (DND)

Department of National Defence (DND) has issued 727 procurement notices on BidsFactory, including 138 currently open and 59 awarded contracts. Activity concentrates in Governance & Public Administration, Trade & Commerce, and Security, Defense & Justice. All notices are published for Canada. Notices are distributed via CanadaBuys - Government of Canada. Most recent publication: June 2, 2026.

Frequently asked questions about this tender

When does this tender close?

The submission deadline is June 16, 2026. You have 13 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Department of National Defence (DND) in Canada. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Consulting contract in the Architecture & Engineering Services sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Canada. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit CanadaBuys - Government of Canada to access the full notice, required documents, and submission instructions provided by the contracting authority.